(Q45255243)

11 December 2017

Comparison of the effects of mirtazapine and fluoxetine in severely depressed patients (English)

1 reference

11 December 2017

1 reference

Marcio Versiani

1

1 reference

11 December 2017

Ricardo Moreno

2

1 reference

11 December 2017

Catharina J A Ramakers-van Moorsel

3

1 reference

11 December 2017

Albert J Schutte

4

1 reference

11 December 2017

Comparative Efficacy Antidepressants Study Group

5

1 reference

11 December 2017

1 January 2005

1 reference

11 December 2017

1 reference

11 December 2017

19

1 reference

11 December 2017

137-146

1 reference

11 December 2017

2

1 reference

https://scigraph.springernature.com/pub.10.2165/00023210-200519020-00004

11 December 2017

0 references

cites work

The economic burden of depression and the cost-effectiveness of treatment.

1 reference

12 December 2020

Severe depression: is there a best approach?

1 reference

12 December 2020

What is meant by intention to treat analysis? Survey of published randomised controlled trials

1 reference

12 December 2020

Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study

1 reference

12 December 2020

Quality of Life Enjoyment and Satisfaction Questionnaire: a new measure

1 reference

12 December 2020

Paroxetine: a selective serotonin reuptake inhibitor showing better tolerance, but weaker antidepressant effect than clomipramine in a controlled multicenter study. Danish University Antidepressant Group

1 reference

12 December 2020

Treatment of severe depression with the selective serotonin reuptake inhibitors

1 reference

12 December 2020

Subjective assessment of the effects of CNS-active drugs on sleep by the Leeds sleep evaluation questionnaire: a review

1 reference

12 December 2020

Mirtazapine: a review of its use in major depression

1 reference

12 December 2020

The pharmacologic profile of mirtazapine

1 reference

12 December 2020

Tolerability and safety aspects of mirtazapine

1 reference

12 December 2020

Double-blind comparison of fluoxetine and nortriptyline in the treatment of moderate to severe major depression

1 reference

12 December 2020

A review of the pharmacological and clinical profile of mirtazapine

1 reference

12 December 2020

A double-blind, randomized, group-comparative study of the tolerability and efficacy of 6 weeks' treatment with mirtazapine or fluoxetine in depressed Chinese patients.

1 reference

12 December 2020

Efficacy, adverse events, and treatment discontinuations in fluoxetine clinical studies of major depression: a meta-analysis of the 20-mg/day dose

1 reference

12 December 2020

Comparative efficacy of selective serotonin reuptake inhibitors and tricyclics in the treatment of melancholia

1 reference

12 December 2020

Efficacy of SSRIs and newer antidepressants in severe depression: comparison with TCAs

1 reference

12 December 2020

Mirtazapine in major depression with comorbid generalized anxiety disorder

1 reference

12 December 2020

A double-blind comparison of venlafaxine and fluoxetine in patients hospitalized for major depression and melancholia. The Venlafaxine French Inpatient Study Group

1 reference

12 December 2020

Severity of depression and response to fluoxetine

1 reference

12 December 2020

Citalopram: clinical effect profile in comparison with clomipramine. A controlled multicenter study. Danish University Antidepressant Group

1 reference

12 December 2020

Is severe depression a separate indication? ECNP Consensus Meeting September 20, 1996, Amsterdam. European College of Neuropsychopharmacology

1 reference

12 December 2020

A Canadian multicenter, double-blind study of paroxetine and fluoxetine in major depressive disorder

1 reference

12 December 2020

Mirtazapine: efficacy and tolerability in comparison with fluoxetine in patients with moderate to severe major depressive disorder. Mirtazapine-Fluoxetine Study Group.

1 reference

12 December 2020

Comparative effects of mirtazapine and fluoxetine on sleep physiology measures in patients with major depression and insomnia

1 reference

12 December 2020

The pharmacology of putative early-onset antidepressant strategies

1 reference

12 December 2020

Antidepressant treatment of the depressed patient with insomnia.

1 reference

12 December 2020

Comparison of sexual functioning in clinical and nonclinical populations using the Changes in Sexual Functioning Questionnaire (CSFQ).

1 reference

12 December 2020

A fixed-dose clinical trial of fluoxetine in outpatients with major depression

1 reference

12 December 2020

Cost of depression among adults in England in 2000.

1 reference

12 December 2020

A placebo controlled investigation into the effects of paroxetine and mirtazapine on measures related to car driving performance.

1 reference

12 December 2020

10.2165/00023210-200519020-00004

Identifiers

DOI

1 reference

Dimensions Publication ID

11 December 2017

1006075950

0 references

Fatcat ID

release_5tr2a2m24ra7jknnwz26xsvojm

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/5tr2a2m24ra7jknnwz26xsvojm

24 November 2022

mapped directly with Wikidata item

1 reference